Durysta Implant
Product Images NDC 0023-9652

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Durysta (NDC 0023-9652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Durysta 01)

Figure 1 (Durysta 01)
FDA Label Image

Figure 2 (Durysta 02)

Figure 2 (Durysta 02)
FDA Label Image

The Structural Formula For Durysta Is An Intracameral Implant Containing 10 Mcg Bimatoprost In The Novadur® Solid Polymer Sustained-release Drug Delivery System (dds). Durysta Is Preloaded Into A Single-use, Dds Applicator To Facilitate Injection Of The Rod-shaped Implant Directly Into The Anterior Chamber Of The Eye. The Components Of The Implant Are Bimatoprost Drug Substance And Polymers Poly (d,l-lactide), Poly (d,l-lactide-co-glycolide), And Polyethylene Glycol. The Chemical Name For Bimatoprost Is (z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(1e,3s)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-n-ethyl-5-heptenamide, And Its Molecular Weight Is 415.57. Its Molecular Formula Is C25h37no4. (Durysta 03)

The Structural Formula For Durysta Is An Intracameral Implant Containing 10 Mcg Bimatoprost In The Novadur® Solid Polymer Sustained-release Drug Delivery System (dds). Durysta Is Preloaded Into A Single-use, Dds Applicator To Facilitate Injection Of The Rod-shaped Implant Directly Into The Anterior Chamber Of The Eye. The Components Of The Implant Are Bimatoprost Drug Substance And Polymers Poly (d,l-lactide), Poly (d,l-lactide-co-glycolide), And Polyethylene Glycol. The Chemical Name For Bimatoprost Is (z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(1e,3s)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-n-ethyl-5-heptenamide, And Its Molecular Weight Is 415.57. Its Molecular Formula Is C25h37no4. (Durysta 03)
FDA Label Image

Figure 3: Study 1 Mean Iop (mmhg) By Treatment Group And Treatment Difference In Mean Iop (Durysta 04)

Figure 3: Study 1 Mean Iop (mmhg) By Treatment Group And Treatment Difference In Mean Iop (Durysta 04)
FDA Label Image

Figure 4: Study 2 Mean Iop (mmhg) By Treatment Group And Treatment Difference In Mean Iop (Durysta 05)

Figure 4: Study 2 Mean Iop (mmhg) By Treatment Group And Treatment Difference In Mean Iop (Durysta 05)
FDA Label Image

Principal Display Paneldurystatm(bimatoprost Implant) 10 Mcgndc 0023-9652-01 (Durysta 07)

Principal Display Paneldurystatm(bimatoprost Implant) 10 Mcgndc 0023-9652-01 (Durysta 07)